loadpatents
name:-0.031438112258911
name:-0.011246919631958
name:-0.0024890899658203
LIN; Chia-Yang Patent Filings

LIN; Chia-Yang

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIN; Chia-Yang.The latest application filed is for "n-terminal scfv multispecific binding molecules".

Company Profile
4.10.33
  • LIN; Chia-Yang - Scarsdale NY
  • LIN; Chia Yang - San Francisco CA
  • LIN; Chia-Yang - Palo Alto CA
  • Lin; Chia-Yang - London GB
  • LIN; Chia-Yang - New Taipei City TW
  • Lin; Chia-Yang - Mountain View CA
  • Lin; Chia-Yang - Taoyuan Hsien TW
  • Lin, Chia-Yang - Kuei-Shan Hsian TW
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES
App 20220251220 - SHEN; Yang ;   et al.
2022-08-11
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof
App 20220251244 - Haber; Lauric ;   et al.
2022-08-11
Novel Il2 Agonists And Methods Of Use Thereof
App 20220220182 - WU; Jiaxi ;   et al.
2022-07-14
Compositions And Methods For Using Bispecific Antibodies To Bind Complement And A Target Antigen
App 20220153819 - Kyratsous; Christos ;   et al.
2022-05-19
User Interfaces For Indicating Distance
App 20220084374 - DOUR; Ryan N. ;   et al.
2022-03-17
Display screen or portion thereof with graphical user interface
Grant D945,464 - Amand , et al. March 8, 2
2022-03-08
Novel Il2 Agonists And Methods Of Use Thereof
App 20210187027 - WU; Jiaxi ;   et al.
2021-06-24
Novel Il2 Agonists And Methods Of Use Thereof
App 20210188934 - WU; Jiaxi ;   et al.
2021-06-24
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES
App 20210130477 - SHEN; Yang ;   et al.
2021-05-06
Pd-l1 Antagonist Combination Treatments
App 20210069326 - ANDREWS; Glen Ian ;   et al.
2021-03-11
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof
App 20210047438 - Haber; Lauric ;   et al.
2021-02-18
PD-L1 antagonist combination treatments
Grant 10,869,924 - Andrews , et al. December 22, 2
2020-12-22
EGFR x CD28 MULTISPECIFIC ANTIBODIES
App 20200299388 - Skokos; Dimitris ;   et al.
2020-09-24
Antagonist Anti-il-7 Receptor Antibodies And Methods
App 20180327503 - LIN; CHIA-YANG ;   et al.
2018-11-15
Combination of a PD-1 Axis Binding Antagonist and an ALK Inhibitor for Treating ALK-Negative Cancer
App 20180282415 - LIN; Chia-Yang ;   et al.
2018-10-04
Antagonist anti-IL-7 receptor antibodies and methods
Grant 10,059,772 - Lin , et al. August 28, 2
2018-08-28
Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist
Grant 10,023,649 - Lin , et al. July 17, 2
2018-07-17
PD-L1 Antagonist Combination Treatments
App 20180169232 - ANDREWS; Glen Ian ;   et al.
2018-06-21
Combination Of An Anti-ccr4 Antibody And A 4-1bb Agonist For Treating Cancer
App 20170088627 - Lin; Chia-Yang ;   et al.
2017-03-30
Anti-glucagon Receptor Antibodies And Methods Of Use Thereof
App 20160311912 - Forgie; Alison Jane ;   et al.
2016-10-27
Antagonist Anti-il-7 Receptor Antibodies And Methods
App 20160229917 - LIN; CHIA-YANG ;   et al.
2016-08-11
Method of treating type 1 diabetes with antagonist IL-7 receptor antibodies
Grant 9,346,885 - Lin , et al. May 24, 2
2016-05-24
Human growth hormone receptor antagonist antibodies and methods of use thereof
Grant 9,249,224 - Siebel , et al. February 2, 2
2016-02-02
Anti-glucagon receptor antibodies and pharmaceutical compositions thereof
Grant 9,248,189 - Forgie , et al. February 2, 2
2016-02-02
Electrical Plug Connector
App 20150229075 - LIN; Chia-Yang ;   et al.
2015-08-13
Human Growth Hormone Receptor Antagonist Antibodies And Methods Of Use Thereof
App 20140356359 - Siebel; Sara Iva ;   et al.
2014-12-04
Anti-glucagon Receptor Antibodies And Methods Of Use Thereof
App 20140335091 - FORGIE; Alison Jane ;   et al.
2014-11-13
Antagonist Anti-il-7 Receptor Antibodies And Methods
App 20140141018 - LIN; Chia-Yang ;   et al.
2014-05-22
Nucleic acid encoding IL-7 receptor alpha antibody
Grant 8,637,273 - Lin , et al. January 28, 2
2014-01-28
Antagonist Anti-il-7 Receptor Antibodies And Methods
App 20130028916 - Lin; Chia-Yang ;   et al.
2013-01-31
Anti-IL-7 receptor antibodies
Grant 8,298,535 - Lin , et al. October 30, 2
2012-10-30
Glucagon-like Protein-1 Receptor (glp-1r) Agonists For Treating Autoimmune Disorders
App 20120148586 - Chou; Joyce Ching Tsu ;   et al.
2012-06-14
Antagonist Anti-il-7 Receptor Antibodies And Methods
App 20110206698 - Lin; Chia-Yang ;   et al.
2011-08-25
Agonist Anti-trkb Monoclonal Antibodies
App 20100196390 - Lin; Chia-Yang ;   et al.
2010-08-05
TrkB Agonists for Treating Autoimmune Disorders
App 20100086997 - Lin; Chia-Yang ;   et al.
2010-04-08
Methods For Treating Unwanted Weight Loss Or Eating Disorders By Administering A Trkb Agonist
App 20090291897 - Lin; Chia-Yang ;   et al.
2009-11-26
Methods Of Treating Ophthalmic Diseases
App 20090022728 - Lin; Chia-Yang
2009-01-22
Methods Wanted For Treating Unwanted Weight Loss Or Eating Disorders By Administering A Trkb Agonist
App 20070248611 - Lin; Chia-Yang ;   et al.
2007-10-25
Offset level detection method for auto color gain control of analog video signals
Grant 6,671,001 - Lin December 30, 2
2003-12-30
Correction method for auto brightness control light sensors in liquid crystal displays
App 20020118161 - Lin, Chia-Yang
2002-08-29
Offset level detection method for auto color gain control of analog video signals
App 20020118305 - Lin, Chia-Yang
2002-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed